These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10203040)

  • 1. Apoptosis and the CD95 system in HIV disease: impact of highly active anti-retroviral therapy (HAART).
    Gougeon ML; Lecoeur H; Sasaki Y
    Immunol Lett; 1999 Mar; 66(1-3):97-103. PubMed ID: 10203040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normalization of CD4+ cell numbers and reduced levels of memory CD8+ cells in blood and tonsillar tissue after highly active antiretroviral therapy in early HIV type-1 infection.
    Dyrhol-Riise AM; Voltersvik P; Røsok BI; Olofsson J; Asjö B
    AIDS Res Hum Retroviruses; 2000 Feb; 16(3):191-201. PubMed ID: 10710207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early T-cell apoptosis and Fas expression during antiretroviral therapy in individuals infected with human immunodeficiency virus-1.
    Aries SP; Weyrich K; Schaaf B; Hansen F; Dennin RH; Dalhoff K
    Scand J Immunol; 1998 Jul; 48(1):86-91. PubMed ID: 9714415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+CD7-lymphocyte subset is expanded in HIV-infected patients with low CD4 cell count rescue during highly active antiretroviral therapy.
    Meroni L; Varchetta S; Manganaro D; Moscatelli G; Moroni M; Galli M
    AIDS; 1999 Apr; 13(5):621-2. PubMed ID: 10203388
    [No Abstract]   [Full Text] [Related]  

  • 5. Spontaneous and anti-Fas-induced apoptosis in lymphocytes from HIV-infected patients undergoing highly active anti-retroviral therapy.
    Grelli S; Campagna S; Lichtner M; Ricci G; Vella S; Vullo V; Montella F; Di Fabio S; Favalli C; Mastino A; Macchi B
    AIDS; 2000 May; 14(8):939-49. PubMed ID: 10853975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.
    Autran B; Carcelain G; Li TS; Blanc C; Mathez D; Tubiana R; Katlama C; Debré P; Leibowitch J
    Science; 1997 Jul; 277(5322):112-6. PubMed ID: 9204894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in cellular activation and apoptosis in HIV-infected patients receiving protease inhibitors or nonnucleoside reverse transcriptase inhibitors.
    Benito JM; López M; Martín JC; Lozano S; Martínez P; González-Lahoz J; Soriano V
    AIDS Res Hum Retroviruses; 2002 Dec; 18(18):1379-88. PubMed ID: 12487809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly active anti-retroviral therapy (HAART) is associated with a lower level of CD4+ T cell apoptosis in HIV-infected patients.
    Roger PM; Breittmayer JP; Arlotto C; Pugliese P; Pradier C; Bernard-Pomier G; Dellamonica P; Bernard A
    Clin Exp Immunol; 1999 Dec; 118(3):412-6. PubMed ID: 10594560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of Bcl-2, but not of Bax or Bcl-x, is associated with T lymphocyte apoptosis in HIV infection and restored by antiretroviral therapy or by interleukin 2.
    Regamey N; Harr T; Battegay M; Erb P
    AIDS Res Hum Retroviruses; 1999 Jun; 15(9):803-10. PubMed ID: 10381168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of viral load and immune complex load on CD4+ lymphocytes as a consequence of highly active antiretroviral treatment (HAART) in HIV-infected hemophilia patients.
    Daniel V; Süsal C; Melk A; Weimer R; Kröpelin M; Zimmermann R; Huth-Kühne A; Uhle C; Opelz G
    Immunol Lett; 1999 Aug; 69(2):283-9. PubMed ID: 10482364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase.
    Lederman MM; McKinnis R; Kelleher D; Cutrell A; Mellors J; Neisler M; Cooney E; Haas DW; Haubrich R; Stanford J; Horton J; Landay A; Spreen W
    AIDS; 2000 Dec; 14(17):2635-42. PubMed ID: 11125881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of the immune system with anti-retroviral therapy.
    Autran B; Carcelaint G; Li TS; Gorochov G; Blanc C; Renaud M; Durali M; Mathez D; Calvez V; Leibowitch J; Katlama C; Debré P
    Immunol Lett; 1999 Mar; 66(1-3):207-11. PubMed ID: 10203056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot study of the effects of intermittent interleukin-2 on human immunodeficiency virus (HIV)-specific immune responses in patients treated during recently acquired HIV infection.
    Dybul M; Hidalgo B; Chun TW; Belson M; Migueles SA; Justement JS; Herpin B; Perry C; Hallahan CW; Davey RT; Metcalf JA; Connors M; Fauci AS
    J Infect Dis; 2002 Jan; 185(1):61-8. PubMed ID: 11756982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parallel decline of CD8+/CD38++ T cells and viraemia in response to quadruple highly active antiretroviral therapy in primary HIV infection.
    Tilling R; Kinloch S; Goh LE; Cooper D; Perrin L; Lampe F; Zaunders J; Hoen B; Tsoukas C; Andersson J; Janossy G;
    AIDS; 2002 Mar; 16(4):589-96. PubMed ID: 11873002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.
    Plana M; García F; Gallart T; Tortajada C; Soriano A; Palou E; Maleno MJ; Barceló JJ; Vidal C; Cruceta A; Miró JM; Gatell JM
    AIDS; 2000 Sep; 14(13):1921-33. PubMed ID: 10997396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naive CD4+ T lymphocytes express high levels of Bcl-2 after highly active antiretroviral therapy for HIV infection.
    Airò P; Torti C; Uccelli MC; Malacarne F; Palvarini L; Carosi G; Castelli F
    AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1805-7. PubMed ID: 11118066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
    Gray CM; Schapiro JM; Winters MA; Merigan TC
    AIDS Res Hum Retroviruses; 1998 May; 14(7):561-9. PubMed ID: 9591710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocytes proliferate in blood and lymph nodes following interleukin-2 therapy in addition to highly active antiretroviral therapy.
    Hengge UR; Borchard C; Esser S; Schröder M; Mirmohammadsadegh A; Goos M
    AIDS; 2002 Jan; 16(2):151-60. PubMed ID: 11807298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy.
    García F; Plana M; Vidal C; Cruceta A; O'Brien WA; Pantaleo G; Pumarola T; Gallart T; Miró JM; Gatell JM
    AIDS; 1999 Jul; 13(11):F79-86. PubMed ID: 10449278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma.
    Powles T; Imami N; Nelson M; Gazzard BG; Bower M
    AIDS; 2002 Mar; 16(4):531-6. PubMed ID: 11872995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.